Skip to content
Screener

Aligos Therapeutics, Inc. ALGS Q4 2025 Annual earnings

Reported March 5, 2026 · Before market open

Revenue$169.0KMiss by $271.0K
EPS-$1.91Beat by $0.58
Revenue estimate$440.0K
EPS estimate-$2.49

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$4.9M
EPS estimate-$2.44

FAQ

When did Aligos Therapeutics, Inc. report Q4 2025 earnings?
Aligos Therapeutics, Inc. (ALGS) reported Q4 2025 earnings on March 5, 2026 before market open.
What were Aligos Therapeutics, Inc.'s Q4 2025 revenue and EPS?
Aligos Therapeutics, Inc. reported revenue of $169.0K and eps of $-1.91 for Q4 2025.
Did Aligos Therapeutics, Inc. beat estimates in Q4 2025?
Revenue missed the consensus estimate of $440.0K by $271.0K. EPS beat the consensus estimate of $-2.49 by $0.58.
How did Aligos Therapeutics, Inc.'s Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 73.1% from $629.0K a year earlier and eps grew 44.0% from $-3.41.
Where can I find Aligos Therapeutics, Inc.'s Q4 2025 SEC filings?
You can read the 8-K earnings release (0001171843-26-001340) and the 10-K periodic report (0001193125-26-092614) directly on SEC EDGAR. The filing index links above go to sec.gov.